Hepatitis C and alcohol

被引:57
作者
Degos, F [1 ]
机构
[1] Hop Beaujon, Serv Hepatol, F-92110 Clichy, France
关键词
alcohol consumption; hepatitis C;
D O I
10.1016/S0168-8278(99)80386-9
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
A close relationship and possible interaction has been noted between alcohol intake and hepatitis C virus infection, since the discovery of HCV markers. It is not understood whether these are additive or synergistic effects in causing liver injury. Interactions between alcohol and HCV may be studied at several levels, including epidemiology, virology (including viral load), histology (effect on the severity of liver lesions), carcinogenesis (the role of alcohol in the occurrence of hepatocellular carcinoma), and the effect on the extrahepatic manifestations or severity of HCV infection. At the epidemiological level, a high prevalence of HCV infection was noted in patients with alcoholic liver diseases (14-37%), also characterized by a high rate of viral replication as detected by PCR, which was present in over 90% of patients tested. Moreover, the prevalence of anti-HCV antibodies increased proportionally with the severity of liver lesions. Virological analysis based on the determination of HCV RNA levels in the serum showed variations of HCV RNA levels with diet, and a clear relationship between self reported alcohol consumption and the levels of serum HCV RNA (r=.26, p=.001). At the histologic level the role of alcohol may be evaluated either through the development of fibrosis or by determination of the incidence of cirrhosis. A study on the effect of alcohol intake below or over 40 g per day on the histologic progression of liver lesions has confirmed a more rapid increase in fibrosis and a doubling in the incidence of cirrhosis in patients admitting to alcohol consumption >40 g per day. The role of alcohol in the occurrence of hepatocellular carcinoma in patients with cirrhosis due to HCV infection has been extensively studied with controversial results. A recent case control study performed in Italy showed that the relative risk of HCC in patients with HCV infection and heavy alcohol consumption doubled. Finally, alcohol consumption potentially worsens the evolution of dermatological diseases associated with HCV infection such as porphyria cutanea tarda. All of the above are strong arguments which should be used to advise HCV patients against alcohol consumption, regardless of the degree of liver injury. However, the deleterious effect of the occasional intake of small amounts of alcohol has not been demonstrated and therefore an occasional drink may be allowed in some cases.
引用
收藏
页码:113 / 118
页数:6
相关论文
共 75 条
  • [41] NAVAS S, 1995, HEPATOLOGY, V21, P279, DOI 10.1016/0270-9139(95)90081-0
  • [42] NISHIGUCHI S, 1991, HEPATOLOGY, V14, P985, DOI 10.1002/hep.1840140606
  • [43] Progression of type C chronic hepatitis to liver cirrhosis and hepatocellular carcinoma - Its relationship to alcohol drinking and the age of transfusion
    Noda, K
    Yoshihara, H
    Suzuki, K
    Yamada, Y
    Kasahara, A
    Hayashi, N
    Fusamoto, H
    Kamada, T
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1996, 20 (01) : A95 - A100
  • [44] Consumption of alcohol in the presence of hepatitis C virus is an additive risk for liver damage
    Ohta, S
    Watanabe, Y
    Nakajima, T
    [J]. PREVENTIVE MEDICINE, 1998, 27 (03) : 461 - 469
  • [45] EFFICACY OF INTERFERON THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C - COMPARISON BETWEEN NONDRINKERS AND DRINKERS
    OKAZAKI, T
    YOSHIHARA, H
    SUZUKI, K
    YAMADA, Y
    TSUJIMURA, T
    KAWANO, K
    YAMADA, Y
    ABE, H
    [J]. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1994, 29 (11) : 1039 - 1043
  • [46] OSHITA M, 1994, HEPATOLOGY, V20, P1115
  • [47] Role of alcohol in the progression of liver disease caused by hepatitis C virus infection
    Ostapowicz, G
    Watson, KJR
    Locarnini, SA
    Desmond, PV
    [J]. HEPATOLOGY, 1998, 27 (06) : 1730 - 1735
  • [48] Effect of alcohol consumption on serum hepatitis C virus RNA and histological lesions in chronic hepatitis C
    Pessione, F
    Degos, F
    Marcellin, P
    Duchatelle, V
    Njapoum, C
    Martinot-Peignoux, M
    Degott, C
    Valla, D
    Erlinger, S
    Rueff, B
    [J]. HEPATOLOGY, 1998, 27 (06) : 1717 - 1722
  • [49] PETERS M, 1994, Z GASTROENTEROL, V32, P146
  • [50] Factors associated with serum HCV RNA positivity in anti-HCV antibody positive intravenous drug users
    Pirisi, M
    Toniutto, P
    Fabris, C
    Lombardelli, T
    Falleti, E
    Tisminetzky, SG
    Baralle, F
    Bartoli, E
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 1998, 51 (05) : 423 - 427